{"entity":{"id":"jurgen-kuball","kind":"person","name":"Jürgen Kuball","aka":[],"tldr":"Utrecht haematologist and immunotherapy researcher on the daily board of UMC Utrecht's cancer programme, known for gamma-delta T cell receptor-engineered cell therapies.","summary":"Jürgen Kuball is Professor of Haematology at UMC Utrecht and a member of the Daily Board of its Strategic Program Cancer. He leads the haematology department and a translational research group developing gamma-delta T cell receptor-based cellular immunotherapies for haematological and solid cancers. His work spans allogeneic stem cell transplantation and engineered T cell products.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://research.umcutrecht.nl/strategic-programs/cancer/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Kuball+J%5BAuthor%5D"}],"tags":["leadership","clinician-scientist","haematology","immunotherapy"],"related":[],"cancers":["aml","multiple-myeloma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["umc-utrecht"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["haematologica"],"dependsOn":[],"notes":[],"role":"Daily Board member, Strategic Program Cancer","institutionId":"umc-utrecht","specialisms":["Haematology","Cellular immunotherapy","Stem cell transplantation"],"profiles":[{"label":"Institution profile","url":"https://research.umcutrecht.nl/strategic-programs/cancer/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Kuball+J%5BAuthor%5D"}],"papers":[{"title":"Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis","journal":"The Lancet Haematology","year":2019,"doi":"10.1016/s2352-3026(19)30158-9"},{"title":"Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma","journal":"Haematologica","year":2016,"doi":"10.3324/haematol.2015.137620"},{"title":"Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis","journal":"The Lancet Haematology","year":2015,"doi":"10.1016/s2352-3026(15)00148-9"}],"orcid":"0000-0002-3914-7806"},"route":"/people/jurgen-kuball/","neighbours":{"cancer":[{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"},{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"}],"institution":[{"id":"umc-utrecht","kind":"institution","name":"UMC Utrecht Cancer Center","route":"/institutions/umc-utrecht/"}],"journal":[{"id":"haematologica","kind":"journal","name":"Haematologica","route":"/journals/haematologica/"}]}}